Related Experiment Video
Updated: Jan 7, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Altered PTPN13-β-catenin interaction by pathogenic mutations and involvement of this axis in B-cell receptor
David A Cabrera-Riofrío1,2, Hongbing Li3, Clara García-Calvo1,2
1Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Plaza Doctores de la Reina, s/n, Salamanca, 37007, Spain.
Abstract:
Protein tyrosine phosphatase non-receptor type 13 (PTPN13) is a non-receptor protein tyrosine phosphatase with context-dependent roles as tumour suppressor or promoter. Its modular structure supports multiple molecular interactions, including a critical one with β-catenin, a regulator of the haematopoietic system. We previously identified three pathogenic PTPN13 mutations in families with acute lymphoblastic leukaemia (ALL), anaemia, and/or inherited bone marrow failure (IBMF). Our current findings reveal that these mutations impair the PTPN13-β-catenin interaction. β-catenin and PTPN13 are stabilised upon B-cell receptor (BCR) activation, while PTPN13 silencing reduces Bruton's tyrosine kinase (BTK) activation and β-catenin levels, indicating that PTPN13 modulates BCR signalling at multiple points. Together with prior evidence showing that PTPN13 mutations compromise protein stability and decrease β-catenin levels, these data support a role for disrupted lymphoid signalling. Altered expression of key surface markers (CD25 and CD38) upon silencing of either PTPN13 or β-catenin further supports this interpretation. In conclusion, our study identifies the PTPN13-β-catenin axis as a critical regulator of lymphoid cell homeostasis and highlights its disruption as a potential driver of haematological abnormalities in patients carrying PTPN13 mutations.
Insights
Protein tyrosine phosphatase non-receptor type 13 (PTPN13) mutations disrupt its interaction with β-catenin, impacting B-cell receptor signaling. This disruption contributes to lymphoid cell abnormalities and potential hematological disorders.
Area of Science:
- Molecular Biology
- Hematology
- Cellular Signaling
Background:
- Protein tyrosine phosphatase non-receptor type 13 (PTPN13) has dual roles in cancer.
- PTPN13 interacts with β-catenin, a key regulator of the hematopoietic system.
- PTPN13 mutations are linked to acute lymphoblastic leukemia (ALL), anemia, and inherited bone marrow failure (IBMF).
Purpose of the Study:
- To investigate the functional consequences of PTPN13 mutations on the PTPN13-β-catenin interaction.
- To elucidate the role of PTPN13 in B-cell receptor (BCR) signaling and lymphoid cell homeostasis.
- To establish the PTPN13-β-catenin axis as a potential driver of hematological abnormalities.
Main Methods:
- Analysis of PTPN13 mutations in patient families.
- Assessment of PTPN13-β-catenin interaction.
- Investigation of BCR signaling components (e.g., BTK activation) upon PTPN13 modulation.
- Flow cytometry analysis of lymphoid cell surface markers (CD25, CD38).
Main Results:
- Identified PTPN13 mutations impair the PTPN13-β-catenin interaction.
- PTPN13 stabilizes β-catenin upon BCR activation.
- PTPN13 silencing reduces Bruton's tyrosine kinase (BTK) activation and β-catenin levels.
- Silencing PTPN13 or β-catenin alters CD25 and CD38 expression on lymphoid cells.
Conclusions:
- The PTPN13-β-catenin axis is crucial for lymphoid cell homeostasis.
- Disruption of this axis due to PTPN13 mutations can drive hematological abnormalities.
- PTPN13 plays a significant role in modulating BCR signaling pathways.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

